Skip to main content
Clinical Trials/NCT04484376
NCT04484376
Completed
Not Applicable

Predictive Factors of Mortality in Invasive Fungal Disease in Post-surgical Critical Care Unit

Hospital Universitario La Fe1 site in 1 country134 target enrollmentMay 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fungal Invasive Disease
Sponsor
Hospital Universitario La Fe
Enrollment
134
Locations
1
Primary Endpoint
Patients mortality
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Invasive fungal disease in the critically ill patient is a serious complication that increases hospitalization times, morbidity and mortality, and healthcare costs.

Our team proposes a retrospective observational study of patients from the resuscitation unit of the Hospital la Fe who during the years 2016-2019 presented invasive candidiasis. The investigators intend to detect if there are possible specific risk factors that favor the development of invasive candidiasis in colonized patients and if these associated risk factors could be considered as 'triggers' or alerts for the implementation of specific care in these patients.

To do this, the investigators intend to study the blood samples taken from patients, taking into account different types of perioperative variables from them, which will be statistically analyzed, so that evidence-based inferences can be drawn to demonstrate our hypothesis.

Detailed Description

The hypothesis is that there are factors predisposing to the development of invasive fungal disease, invasive candidiasis, and that the detection of these factors may allow detecting the population at risk and implementing both pharmacological measures and general strategies to reduce the mortality of fungal infection. Primary objective: To determine if candida auris is associated with increased risk of mortality in invasive fungal disease and the risk factors for mortality in the invasive fungal disease, including the species of candida that causes this disease. Secondary objectives: Determination of predictors of mortality in invasive fungal disease. Prepare and validate a score in our environment that allows discriminating those patients with a high risk of mortality. To analyze the pharmacological management that has been carried out in patients who develop candidemia due to auris. Detect hospital stays of both population groups, in terms of health management. Type of study: observational, longitudinal, and retrospective study of cases and controls of a selected exposed population that developed the disease over time or not.

Registry
clinicaltrials.gov
Start Date
May 1, 2016
End Date
January 1, 2019
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Oscar Diaz-Cambronero

Principal Investigator

Hospital Universitario La Fe

Eligibility Criteria

Inclusion Criteria

  • More than 18 years
  • Admitted to the ICU that present fungal invasive disease

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Patients mortality

Time Frame: Hospital stay (up to 6 months)

Number of patients with fungal disease related fatal outcome from diagnosis to end of hospital stay.

Study Sites (1)

Loading locations...

Similar Trials